Download Files:
Products Details
Product Description
– KRAS G12C inhibitor 21 is a KRAS G12C inhibitor extracted from patent WO2021219090A1, example 7[1].
Web ID
– HY-145018
Shipping
– Room temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C34H30ClN3O4
References
– [1]Quinoxaline dione derivative as irreversible inhibitor of kras g12c mutant protein. WO2021219090A1.
CAS Number
– 2737269-61-1
Molecular Weight
– 580.07
SMILES
– O=C(N1CC(C1)CN2C(C(N(C3=C2C=C(Cl)C(C4=C5C=CC=CC5=CC(O)=C4)=C3)C6=C(C(C)C)C=CC=C6)=O)=O)C=C
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Ras
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
